These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32947564)

  • 1. Lipidomics in Nonalcoholic Fatty Liver Disease: Exploring Serum Lipids as Biomarkers for Pediatric Nonalcoholic Fatty Liver Disease.
    Draijer LG; Froon-Torenstra D; van Weeghel M; Vaz FM; Bohte AE; Holleboom AG; Benninga MA; Koot BGP
    J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):433-439. PubMed ID: 32947564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
    Zhou M; Liu X; Wu Y; Xiang Q; Yu R
    J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease stratification by liver lipidomics.
    Vvedenskaya O; Rose TD; Knittelfelder O; Palladini A; Wodke JAH; Schuhmann K; Ackerman JM; Wang Y; Has C; Brosch M; Thangapandi VR; Buch S; Züllig T; Hartler J; Köfeler HC; Röcken C; Coskun Ü; Klipp E; von Schoenfels W; Gross J; Schafmayer C; Hampe J; Pauling JK; Shevchenko A
    J Lipid Res; 2021; 62():100104. PubMed ID: 34384788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review of lipidomics in nonalcoholic fatty liver disease.
    Béland-Bonenfant S; Rouland A; Petit JM; Vergès B
    Diabetes Metab; 2023 May; 49(3):101432. PubMed ID: 36781065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
    Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease.
    Mato JM; Alonso C; Noureddin M; Lu SC
    World J Gastroenterol; 2019 Jun; 25(24):3009-3020. PubMed ID: 31293337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach.
    Mouskeftara T; Kalopitas G; Liapikos T; Arvanitakis K; Germanidis G; Gika H
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
    Gorden DL; Ivanova PT; Myers DS; McIntyre JO; VanSaun MN; Wright JK; Matrisian LM; Brown HA
    PLoS One; 2011; 6(8):e22775. PubMed ID: 21857953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.
    Flores YN; Amoon AT; Su B; Velazquez-Cruz R; Ramírez-Palacios P; Salmerón J; Rivera-Paredez B; Sinsheimer JS; Lusis AJ; Huertas-Vazquez A; Saab S; Glenn BA; May FP; Williams KJ; Bastani R; Bensinger SJ
    Lipids Health Dis; 2021 Oct; 20(1):136. PubMed ID: 34629052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis.
    Li H; Xu QY; Xie Y; Luo JJ; Cao HX; Pan Q
    Ann Hepatol; 2021; 24():100316. PubMed ID: 33515803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet.
    Oliveira DT; Chaves-Filho AB; Yoshinaga MY; Paiva NCN; Carneiro CM; Miyamoto S; Festuccia WT; Guerra-Sá R
    J Nutr Biochem; 2021 Jan; 87():108519. PubMed ID: 33017610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.
    Sa R; Zhang W; Ge J; Wei X; Zhou Y; Landzberg DR; Wang Z; Han X; Chen L; Yin H
    J Mol Cell Biol; 2016 Jun; 8(3):195-206. PubMed ID: 26993042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation.
    Yang X; Sun L; Feng D; Deng Y; Liao W
    J Nutr Biochem; 2023 Aug; 118():109353. PubMed ID: 37116815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.
    Velenosi TJ; Ben-Yakov G; Podszun MC; Hercun J; Etzion O; Yang S; Nadal C; Haynes-Williams V; Huang WA; González-Hódar L; Brychta RJ; Takahashi S; Akkaraju V; Krausz KW; Walter M; Cai H; Walter PJ; Muniyappa R; Chen KY; Gonzalez FJ; Rotman Y
    Gastroenterology; 2022 Jun; 162(7):1990-2003. PubMed ID: 35283114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics.
    Di Sessa A; Riccio S; Pirozzi E; Verde M; Passaro AP; Umano GR; Guarino S; Miraglia Del Giudice E; Marzuillo P
    World J Gastroenterol; 2021 Jul; 27(25):3815-3824. PubMed ID: 34321846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.